Immatics (IMTX) Current Taxes (2024 - 2025)
Immatics (IMTX) posted Current Taxes of $2.7 million for Q4 2025, up 35.36% sequentially from $2.0 million in Q2 2025, and up 25.75% YoY from $2.1 million in Q4 2024.
Immatics (IMTX) Current Taxes (2024 - 2025) Analysis & Trends
Immatics has reported Current Taxes for 2 years, with the latest figure at $2.7 million in Q4 2025.
- Quarterly Current Taxes rose 25.75% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 25.75% YoY) and the FY2025 annual result came in at $2.6 million, up 20.5% from the prior year.
- Current Taxes advanced to $2.7 million in Q4 2025 per IMTX's latest filing, from $2.0 million in the prior quarter.
- Over five years, Current Taxes peaked at $2.7 million in Q4 2025 and troughed at $2.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 2.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.70 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.15 Mn |